Implementation of a Novel Order Set to Improve Baseline Pulmonary, Hepatic, and Thyroid Function Testing at Time of Inpatient Amiodarone Initiation

Amiodarone is a chemically-unique class III antiarrhythmic drug and is commonly-prescribed by internists and cardiologists alike.1 In addition to its known blockade of myocardial outward potassium channels and resultant class III properties, amiodarone is pharmacologically complex and exhibits class...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2020-12, Vol.136, p.173-175
Hauptverfasser:	Harmon, Evan, Blackwell, Jacob N., Pan, Jonathan A., Miller, Matthew, Laja, Olusola, Brock, Laurie, Adams, Jason, Dunn, Steven, Voss, John, Mehta, Nishaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Amiodarone Amiodarone - adverse effects Amiodarone - therapeutic use Anti-Arrhythmia Agents - adverse effects Anti-Arrhythmia Agents - therapeutic use Arrhythmias, Cardiac - drug therapy Cardiovascular diseases Coronary artery disease Drug dosages Guidelines Heart diseases Hospitals Humans Lipophilic Liver Liver Function Tests - standards Potassium Potassium channels Respiratory Function Tests - standards Retrospective Studies Therapy Thyroid Thyroid Function Tests - standards Thyroid gland Toxicity Ventricle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!